Now showing items 1-1 of 1

  • Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial) 

    Thorne-Humphrey, L. M.; Goralski, K. B.; Slayter, K. L.; Hatchette, T. F.; Johnston, B. L.; McNeil, S. A.; 2009 OPTIMO Study Grp (2011-09)
    Background: Detailed pharmacokinetics to guide oseltamivir (Tamiflu (R)) dosing in morbidly obese patients is lacking. Methods: The OPTIMO trial was a single-centre, non-randomized, open-label pharmacokinetic study of ...